Nyxoah Aktie
WKN DE: A2QCWK / ISIN: BE0974358906
12.04.2024 03:07:54
|
Nyxoah Appoints Maurits Boon As Chief Medical Officer
(RTTNews) - Nyxoah SA (NYXH) said that it appointed Maurits Boon as Chief Medical Officer.
Boon joins Nyxoah from the Thomas Jefferson University, where he will continue part time as a professor and Vice Chairman, Education. He is dual board-certified in otolaryngology - head and neck surgery, as well as sleep medicine.
Boon is one of two sleep surgeons with Jefferson Health to pioneer the use of hypoglossal nerve stimulation therapy. He has lectured worldwide on obstructive sleep apnea, has numerous publications and is co-editor of the first book on hypoglossal nerve stimulation therapy.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Nyxoah S.A. Registered Shsmehr Nachrichten
03.08.25 |
Erste Schätzungen: Nyxoah vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
22.07.25 |
Erste Schätzungen: Nyxoah legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
14.05.25 |
EQS-News: Nyxoah gibt Finanzergebnisse und operatives Update für das erste Quartal bekannt (EQS Group) | |
14.05.25 |
EQS-News: Nyxoah Reports First Quarter Financial and Operating Results (EQS Group) | |
08.04.25 |
EQS-News: Nyxoah Provides Update on FDA Approvable Letter for Genio System (EQS Group) | |
26.03.25 |
EQS-News: Nyxoah erhält Approvable Letter für sein Genio®-System von der FDA (EQS Group) | |
26.03.25 |
EQS-News: FDA Issues Nyxoah an Approvable Letter for its Genio® System (EQS Group) | |
13.03.25 |
EQS-News: Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results (EQS Group) |
Analysen zu Nyxoah S.A. Registered Shsmehr Analysen
Aktien in diesem Artikel
Nyxoah S.A. Registered Shs | 6,33 | -3,80% |
|